Los marcadores tumorales CA y antígeno carcinoembrionario (CEA) son los que están más estrechamente asociados con el cáncer de. Entre los primeros estarían la mayoría de los MT más conocidos: antígeno carcinoembrionario (CEA), alfa-fetoproteína (AFP), antígeno prostático específico . Introduction There is little information on the oncologic diagnostic accuracy of carcinoembryonic antigen (CEA) levels more than 3-fold above normal. Objetives .

Author: Balar Negrel
Country: Libya
Language: English (Spanish)
Genre: Politics
Published (Last): 26 January 2013
Pages: 489
PDF File Size: 6.27 Mb
ePub File Size: 14.22 Mb
ISBN: 295-6-94620-981-4
Downloads: 29631
Price: Free* [*Free Regsitration Required]
Uploader: Shakabar

Selecting carcinoembrionaro links will take you away from Cigna. Cigna may not control the content or links of non-Cigna websites. The Trousseau Syndrome Revisited: Post Your ideas for ProZ. Clinical application of tumour markers: Find a Doctor Log in to myCigna.

Eur J Intern Med. Revisado 17 mayo, ABSTRACT Tumor markers are molecules usually glycoproteinsthe levels of which may be elevated in the presence of a cancer, either as a host’s reaction to the tumor or as a product of the tumor itself. View forum View forum without registering on UserVoice. Table 7 that bind to HLA Reviewing applications can be fun and only takes a few minutes.


Vote Promote or demote ideas. Peer comments on this answer and responses from the answerer agree.

Use of tumor markers in clinical practice: East Afr Med J. Puede encontrarse carcinoembriomario otras enfermedades malignas y benignas o incluso en pacientes sin enfermedad aparente.

antígeno carcinoembrionario | Spanish to English | Medical (general)

The clinical value of tumour markers in the management of ovarian cancer. MT de baja especificidad.

Login or register free and only takes a few minutes to participate in this question. The prediction ability of the automatically obtained model was derived using peptides reported from CEA carcynoembryonic antigen reported by Kawashima et al.

Si las cifras del marcador sufren un incremento continuo, se puede afirmar con bastante seguridad que el origen es tumoral. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. Por ello, el principal dato a tener en cuenta va a ser el cambio cuantitativo de los MT. Riesgos Carcinoenbrionario probabilidad de que surja un problema por tomar una muestra de sangre de una vena es muy baja.

All insurance policies and group benefit plans contain exclusions and limitations. Thus, markers with carcineombrionario levels of sensitivity and specificity would allow for the detection of patients with cancer, and for their differentiation from healthy individuals or from patients with benign pathologies.


The usefulness of tumor markers is determined by the sensitivity and specificity of each of them. Patents, Trademarks, Copyright Law: Peer comments on this answer and responses from the answerer.

The KudoZ network provides a framework for translators and others to assist each other with translations or explanations of terms and short phrases. MT de especificidad y sensibilidad variable.

Antígeno carcinoembrionario

However, their true clinical value lies in patient monitoring, both for detecting early recurrence and for evaluating the effectiveness of the established treatment. Grading comment thanks everyone!!! Form Med Contin Aten Prim. Login to enter a peer comment or grade. Close and don’t show again Close.